Fast and efficient generation of knock-in human organoids using homology-independent CRISPR/Cas9 precision genome editing — Benedetta Artegiani (2020) | RDL Network
Fast and efficient generation of knock-in human organoids using homology-independent CRISPR/Cas9 precision genome editing
Preprint 2020 en
Authors
BA
Benedetta Artegiani
DH
Delilah Hendriks
JB
Joep Beumer
Abstract
1 min read
Abstract CRISPR/Cas9 technology has revolutionized genome editing and is applicable to the organoid field. However, precise integration of exogenous DNA sequences in human organoids awaits robust knock-in approaches. Here, we describe CRISPR /Cas9-mediated H omology-independent O rganoid T ransgenesis (CRISPR-HOT), which allows efficient generation of knock-in human organoids representing different tissues. CRISPR-HOT avoids extensive cloning and outperforms homology directed repair (HDR) in achieving precise integration of exogenous DNA sequences at desired loci, without the necessity to inactivate TP53 in untransformed cells, previously used to increase HDR-mediated knock-in. CRISPR-HOT was employed to fluorescently tag and visualize subcellular structural molecules and to generate reporter lines for rare intestinal cell types. A double reporter labelling the mitotic spindle by tagged tubulin and the cell membrane by tagged E-cadherin uncovered modes of human hepatocyte division. Combining tubulin tagging with TP53 knock-out revealed TP53 involvement in controlling hepatocyte ploidy and mitotic spindle fidelity. CRISPR-HOT simplifies genome editing in human organoids.
Maarten H. Geurts, Eyleen de Poel, Cayetano Pleguezuelos‐Manzano, Rurika Oka, Léo Carrillo, Amanda Andersson-Rolf, Matteo Boretto, Jesse E Brunsveld, Ruben van Boxtel, Jeffrey M. Beekman, Hans Clevers
Victor Tirolle, Adrien Krug, Emma Bokobza, Mattijs Bulcaen, M. Ensinck, Maarten H. Geurts, Delilah Hendriks, F. Vermeulen, Frédéric Larbret, Alejandra Gutiérrez-Guerrero, Louise Medaer, Rik Gijsbers, Philippe Mangeot, Hans Clevers, Marianne S. Carlon, Frédéric Bost, Els Verhoeyen
Discussion(0)
No comments yet. Be the first to comment.